-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LHUQUc5+xWpswhzdNE7EbZaPiDjtKhlqr5H8lHBCyb7prUIJzEdKwsb1Q9nS8T2D pYA0WQpx/a4Gvlcr18W9lg== 0000891020-01-500430.txt : 20020413 0000891020-01-500430.hdr.sgml : 20020413 ACCESSION NUMBER: 0000891020-01-500430 CONFORMED SUBMISSION TYPE: 424B3 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20011219 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIOJECT MEDICAL TECHNOLOGIES INC CENTRAL INDEX KEY: 0000810084 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 931099680 STATE OF INCORPORATION: OR FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-39421 FILM NUMBER: 1817577 BUSINESS ADDRESS: STREET 1: 7620 S W BRIDGEPORT RD CITY: PORTLAND STATE: OR ZIP: 97224 BUSINESS PHONE: 5036397221 MAIL ADDRESS: STREET 1: 7620 S W BRIDGEPORT ROAD CITY: PORTLAND STATE: OR ZIP: 97224 FORMER COMPANY: FORMER CONFORMED NAME: BIOJECT MEDICAL SYSTEMS LTD DATE OF NAME CHANGE: 19920703 424B3 1 v77987b3e424b3.htm FORM 424B3 DATED DECEMBER 19, 2001 FORM 424B3 FOR BIOJECT MEDICAL
 

     
Prospectus Supplement   Filed Pursuant to Rule 424(b)(3)
(To Prospectus dated January 28, 1998)   SEC File No. 333-39421

BIOJECT MEDICAL TECHNOLOGIES INC.
545,455 Shares of Common Stock

         Elan International Services, Ltd., one of the Selling Shareholders named in the Prospectus, has transferred 545,455 Shares to Elan Pharmaceutical Investments, Ltd., which Shares may be sold pursuant to the Prospectus by Elan Pharmaceutical Investments, Ltd. All share amounts in this Supplement have been adjusted to reflect the 1-for-5 reverse split of the Common Stock effected on October 13, 1999.

         All of the information regarding beneficial ownership set forth below was furnished to us by the Selling Shareholder named below.

                                 
    Shares of   Common                
    Common Stock   Stock                
    beneficially   offered   Shares Owned After Offering
Name of   owned as of   by this  
Selling Shareholder   Dec. 13, 2001   Prospectus   Number   Percent
 
 
 
 
Elan Pharmaceutical Investments, Ltd.
     3,992,5911       545,455       3,447,136       25.9 %

1   Includes 798,121 outstanding shares of Common Stock, 505,334 shares of Common Stock subject to common stock purchase warrants, 1,905,476 shares of Common Stock issuable on conversion of 952,738 outstanding shares of Series A Convertible Preferred Stock, and 783,660 shares of Common Stock issuable on conversion of 391, 830 outstanding shares of Series C Convertible Preferred Stock.

The date of this Prospectus Supplement is December 19, 2001.

-----END PRIVACY-ENHANCED MESSAGE-----